Medicine
Medicine market is segmented by players, region (country), by Type and by Application. Players, s ... Read More
Global Medication Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medication Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Medication Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medication Market Perspective (2017-2028)
2.2 Medication Growth Trends by Region
2.2.1 Medication Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medication Historic Market Size by Region (2017-2022)
2.2.3 Medication Forecasted Market Size by Region (2023-2028)
2.3 Medication Market Dynamics
2.3.1 Medication Industry Trends
2.3.2 Medication Market Drivers
2.3.3 Medication Market Challenges
2.3.4 Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medication Players by Revenue
3.1.1 Global Top Medication Players by Revenue (2017-2022)
3.1.2 Global Medication Revenue Market Share by Players (2017-2022)
3.2 Global Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medication Revenue
3.4 Global Medication Market Concentration Ratio
3.4.1 Global Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medication Revenue in 2021
3.5 Medication Key Players Head office and Area Served
3.6 Key Players Medication Product Solution and Service
3.7 Date of Enter into Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medication Breakdown Data by Type
4.1 Global Medication Historic Market Size by Type (2017-2022)
4.2 Global Medication Forecasted Market Size by Type (2023-2028)
5 Medication Breakdown Data by Application
5.1 Global Medication Historic Market Size by Application (2017-2022)
5.2 Global Medication Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medication Market Size (2017-2028)
6.2 North America Medication Market Size by Country (2017-2022)
6.3 North America Medication Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Medication Market Size (2017-2028)
7.2 Europe Medication Market Size by Country (2017-2022)
7.3 Europe Medication Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medication Market Size (2017-2028)
8.2 Asia-Pacific Medication Market Size by Country (2017-2022)
8.3 Asia-Pacific Medication Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Medication Market Size (2017-2028)
9.2 Latin America Medication Market Size by Country (2017-2022)
9.3 Latin America Medication Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medication Market Size (2017-2028)
10.2 Middle East & Africa Medication Market Size by Country (2017-2022)
10.3 Middle East & Africa Medication Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medication Introduction
11.1.4 Pfizer Revenue in Medication Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Medication Introduction
11.2.4 Roche Revenue in Medication Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Medication Introduction
11.3.4 Sanofi Revenue in Medication Business (2017-2022)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Medication Introduction
11.4.4 Johnson & Johnson Revenue in Medication Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Medication Introduction
11.5.4 Merck & Co. (MSD) Revenue in Medication Business (2017-2022)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Medication Introduction
11.6.4 Novartis Revenue in Medication Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Medication Introduction
11.7.4 AbbVie Revenue in Medication Business (2017-2022)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Medication Introduction
11.8.4 Gilead Sciences Revenue in Medication Business (2017-2022)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Medication Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Medication Business (2017-2022)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Medication Introduction
11.10.4 Amgen Revenue in Medication Business (2017-2022)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Medication Introduction
11.11.4 AstraZeneca Revenue in Medication Business (2017-2022)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Medication Introduction
11.12.4 Bristol-Myers Squibb Revenue in Medication Business (2017-2022)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Medication Introduction
11.13.4 Eli Lilly Revenue in Medication Business (2017-2022)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Medication Introduction
11.14.4 Teva Revenue in Medication Business (2017-2022)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Medication Introduction
11.15.4 Bayer Revenue in Medication Business (2017-2022)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Medication Introduction
11.16.4 Novo Nordisk Revenue in Medication Business (2017-2022)
11.16.5 Novo Nordisk Recent Development
11.17 Allergan
11.17.1 Allergan Company Detail
11.17.2 Allergan Business Overview
11.17.3 Allergan Medication Introduction
11.17.4 Allergan Revenue in Medication Business (2017-2022)
11.17.5 Allergan Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Medication Introduction
11.18.4 Takeda Revenue in Medication Business (2017-2022)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Medication Introduction
11.19.4 Boehringer Ingelheim Revenue in Medication Business (2017-2022)
11.19.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Medication Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Medication Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Medication Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Medication Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Medication Market Share by Region (2017-2022)
Table 8. Global Medication Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Medication Market Share by Region (2023-2028)
Table 10. Medication Market Trends
Table 11. Medication Market Drivers
Table 12. Medication Market Challenges
Table 13. Medication Market Restraints
Table 14. Global Medication Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Medication Market Share by Players (2017-2022)
Table 16. Global Top Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2021)
Table 17. Ranking of Global Top Medication Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Medication Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medication Product Solution and Service
Table 21. Date of Enter into Medication Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medication Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Medication Revenue Market Share by Type (2017-2022)
Table 25. Global Medication Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Medication Revenue Market Share by Type (2023-2028)
Table 27. Global Medication Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Medication Revenue Market Share by Application (2017-2022)
Table 29. Global Medication Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Medication Revenue Market Share by Application (2023-2028)
Table 31. North America Medication Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Medication Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Medication Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Medication Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Medication Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Medication Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Medication Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Medication Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Medication Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Medication Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Company Detail
Table 42. Pfizer Business Overview
Table 43. Pfizer Medication Product
Table 44. Pfizer Revenue in Medication Business (2017-2022) & (US$ Million)
Table 45. Pfizer Recent Development
Table 46. Roche Company Detail
Table 47. Roche Business Overview
Table 48. Roche Medication Product
Table 49. Roche Revenue in Medication Business (2017-2022) & (US$ Million)
Table 50. Roche Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Medication Product
Table 54. Sanofi Revenue in Medication Business (2017-2022) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Medication Product
Table 59. Johnson & Johnson Revenue in Medication Business (2017-2022) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Merck & Co. (MSD) Company Detail
Table 62. Merck & Co. (MSD) Business Overview
Table 63. Merck & Co. (MSD) Medication Product
Table 64. Merck & Co. (MSD) Revenue in Medication Business (2017-2022) & (US$ Million)
Table 65. Merck & Co. (MSD) Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Medication Product
Table 69. Novartis Revenue in Medication Business (2017-2022) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. AbbVie Company Detail
Table 72. AbbVie Business Overview
Table 73. AbbVie Medication Product
Table 74. AbbVie Revenue in Medication Business (2017-2022) & (US$ Million)
Table 75. AbbVie Recent Development
Table 76. Gilead Sciences Company Detail
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Medication Product
Table 79. Gilead Sciences Revenue in Medication Business (2017-2022) & (US$ Million)
Table 80. Gilead Sciences Recent Development
Table 81. GlaxoSmithKline (GSK) Company Detail
Table 82. GlaxoSmithKline (GSK) Business Overview
Table 83. GlaxoSmithKline (GSK) Medication Product
Table 84. GlaxoSmithKline (GSK) Revenue in Medication Business (2017-2022) & (US$ Million)
Table 85. GlaxoSmithKline (GSK) Recent Development
Table 86. Amgen Company Detail
Table 87. Amgen Business Overview
Table 88. Amgen Medication Product
Table 89. Amgen Revenue in Medication Business (2017-2022) & (US$ Million)
Table 90. Amgen Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca MedicationProduct
Table 94. AstraZeneca Revenue in Medication Business (2017-2022) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Bristol-Myers Squibb Company Detail
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb MedicationProduct
Table 99. Bristol-Myers Squibb Revenue in Medication Business (2017-2022) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Eli Lilly Company Detail
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly MedicationProduct
Table 104. Eli Lilly Revenue in Medication Business (2017-2022) & (US$ Million)
Table 105. Eli Lilly Recent Development
Table 106. Teva Company Detail
Table 107. Teva Business Overview
Table 108. Teva MedicationProduct
Table 109. Teva Revenue in Medication Business (2017-2022) & (US$ Million)
Table 110. Teva Recent Development
Table 111. Bayer Company Detail
Table 112. Bayer Business Overview
Table 113. Bayer MedicationProduct
Table 114. Bayer Revenue in Medication Business (2017-2022) & (US$ Million)
Table 115. Bayer Recent Development
Table 116. Novo Nordisk Company Detail
Table 117. Novo Nordisk Business Overview
Table 118. Novo Nordisk MedicationProduct
Table 119. Novo Nordisk Revenue in Medication Business (2017-2022) & (US$ Million)
Table 120. Novo Nordisk Recent Development
Table 121. Allergan Company Detail
Table 122. Allergan Business Overview
Table 123. Allergan MedicationProduct
Table 124. Allergan Revenue in Medication Business (2017-2022) & (US$ Million)
Table 125. Allergan Recent Development
Table 126. Takeda Company Detail
Table 127. Takeda Business Overview
Table 128. Takeda MedicationProduct
Table 129. Takeda Revenue in Medication Business (2017-2022) & (US$ Million)
Table 130. Takeda Recent Development
Table 131. Boehringer Ingelheim Company Detail
Table 132. Boehringer Ingelheim Business Overview
Table 133. Boehringer Ingelheim MedicationProduct
Table 134. Boehringer Ingelheim Revenue in Medication Business (2017-2022) & (US$ Million)
Table 135. Boehringer Ingelheim Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medication Market Share by Type: 2021 VS 2028
Figure 2. Brand Drugs Features
Figure 3. Generic Drug Features
Figure 4. Global Medication Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Medication Report Years Considered
Figure 9. Global Medication Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Medication Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Medication Market Share by Region: 2021 VS 2028
Figure 12. Global Medication Market Share by Players in 2021
Figure 13. Global Top Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Medication Revenue in 2021
Figure 15. North America Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Medication Market Share by Country (2017-2028)
Figure 17. United States Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Medication Market Share by Country (2017-2028)
Figure 21. Germany Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Medication Market Share by Region (2017-2028)
Figure 29. China Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Medication Market Share by Country (2017-2028)
Figure 37. Mexico Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Medication Market Share by Country (2017-2028)
Figure 41. Turkey Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Medication Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer Revenue Growth Rate in Medication Business (2017-2022)
Figure 44. Roche Revenue Growth Rate in Medication Business (2017-2022)
Figure 45. Sanofi Revenue Growth Rate in Medication Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in Medication Business (2017-2022)
Figure 47. Merck & Co. (MSD) Revenue Growth Rate in Medication Business (2017-2022)
Figure 48. Novartis Revenue Growth Rate in Medication Business (2017-2022)
Figure 49. AbbVie Revenue Growth Rate in Medication Business (2017-2022)
Figure 50. Gilead Sciences Revenue Growth Rate in Medication Business (2017-2022)
Figure 51. GlaxoSmithKline (GSK) Revenue Growth Rate in Medication Business (2017-2022)
Figure 52. Amgen Revenue Growth Rate in Medication Business (2017-2022)
Figure 53. AstraZeneca Revenue Growth Rate in Medication Business (2017-2022)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Medication Business (2017-2022)
Figure 55. Eli Lilly Revenue Growth Rate in Medication Business (2017-2022)
Figure 56. Teva Revenue Growth Rate in Medication Business (2017-2022)
Figure 57. Bayer Revenue Growth Rate in Medication Business (2017-2022)
Figure 58. Novo Nordisk Revenue Growth Rate in Medication Business (2017-2022)
Figure 59. Allergan Revenue Growth Rate in Medication Business (2017-2022)
Figure 60. Takeda Revenue Growth Rate in Medication Business (2017-2022)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Medication Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim